<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-22T07:56:00+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>生命科学研究领域又添利器，2020版中国药典正式收录SPR技术丨医麦猛爆料</title>
    <updated>2021-01-21T22:22:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/vywyJ0t2yj5sOKT3HHHk1A</id>
    <link href="https://mp.weixin.qq.com/s/vywyJ0t2yj5sOKT3HHHk1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个CAR-T疗法即将上市，成功的关键是什么？丨医麦猛爆料</title>
    <updated>2021-01-21T22:22:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/m936tvfhbcHuaH1AWaGQ7g</id>
    <link href="https://mp.weixin.qq.com/s/m936tvfhbcHuaH1AWaGQ7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赠书 | 当进行除病毒过滤验证，需要关注什么？</title>
    <updated>2021-01-21T22:22:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/msn7vZWbw3CiDCrevMbfaw</id>
    <link href="https://mp.weixin.qq.com/s/msn7vZWbw3CiDCrevMbfaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>包含五种转基因的溶瘤性单纯疱疹病毒，临床前数据显示出强大的全身性抗肿瘤活性丨医麦猛爆料</title>
    <updated>2021-01-21T22:22:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/AheSOoieFRr96nSLjKVM2w</id>
    <link href="https://mp.weixin.qq.com/s/AheSOoieFRr96nSLjKVM2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨天演药业递交赴美上市申请，拟募资1.25亿美元</title>
    <updated>2021-01-21T22:22:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/ap_wXH6JGrOOP5wQgm5Exg</id>
    <link href="https://mp.weixin.qq.com/s/ap_wXH6JGrOOP5wQgm5Exg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药产业发展新浪潮（下）——细胞和基因疗法研发生产外包服务</title>
    <updated>2021-01-20T17:12:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/ce9i3IK_UsgjkFEUvhPSpg</id>
    <link href="https://mp.weixin.qq.com/s/ce9i3IK_UsgjkFEUvhPSpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亘喜生物基于FasTCAR平台开发的针对复发或难治性B-ALL成年患者的GC019F CAR-T获得IND批准进入注册临床研究</title>
    <updated>2021-01-20T17:12:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/drQbMFJg-OcpYTUHhICPpw</id>
    <link href="https://mp.weixin.qq.com/s/drQbMFJg-OcpYTUHhICPpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒润达生CAR-T细胞治疗迈向产业化，欧盟标准生产基地正式落成丨医麦猛爆料</title>
    <updated>2021-01-20T17:12:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/Kk0Y6rpQqdHZMTITV-l1Jw</id>
    <link href="https://mp.weixin.qq.com/s/Kk0Y6rpQqdHZMTITV-l1Jw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“递送策略”革新之干细胞篇丨医麦新观察</title>
    <updated>2021-01-20T17:12:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/4JQEAz_nBV2LNs5l1XhB0g</id>
    <link href="https://mp.weixin.qq.com/s/4JQEAz_nBV2LNs5l1XhB0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨Immunocore拟募资1亿美元IPO，推进TCR疗法</title>
    <updated>2021-01-20T17:12:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/mpkxC1vlyhc7dt6_W-3-bg</id>
    <link href="https://mp.weixin.qq.com/s/mpkxC1vlyhc7dt6_W-3-bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药产业发展新浪潮（上）——细胞和基因疗法</title>
    <updated>2021-01-19T23:04:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/dtUTXA6B9E2UvZjSMvpDCg</id>
    <link href="https://mp.weixin.qq.com/s/dtUTXA6B9E2UvZjSMvpDCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>纽福斯与AAVnerGene就新一代眼科基因治疗AAV载体技术建立全球战略合作伙伴关系丨医麦猛爆料</title>
    <updated>2021-01-19T23:04:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/dWyDskWNUGhsSPtCEgDutw</id>
    <link href="https://mp.weixin.qq.com/s/dWyDskWNUGhsSPtCEgDutw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature子刊：瘫痪小鼠重新行走，AAV基因疗法潜力无限丨医麦猛爆料</title>
    <updated>2021-01-19T23:04:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/VfLfE2eDuzN_5o3QoVc0kA</id>
    <link href="https://mp.weixin.qq.com/s/VfLfE2eDuzN_5o3QoVc0kA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>斥资逾16亿美元，礼来这次看上双特异性抗体领域丨医麦猛爆料</title>
    <updated>2021-01-19T23:04:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/J3g5JlWvDqPZI8RZOo8nug</id>
    <link href="https://mp.weixin.qq.com/s/J3g5JlWvDqPZI8RZOo8nug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨Vor拟募资1.5亿美元IPO，推进CD33 CAR-T疗法</title>
    <updated>2021-01-19T23:04:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/I6C1loVGOyNmpTjxYMPxDQ</id>
    <link href="https://mp.weixin.qq.com/s/I6C1loVGOyNmpTjxYMPxDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武汉友芝友生物CD38/CD3双抗获临床默示许可，系国内首款丨医麦猛爆料</title>
    <updated>2021-01-19T23:04:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/x9Q5hkik3xApv0dfSc5d_g</id>
    <link href="https://mp.weixin.qq.com/s/x9Q5hkik3xApv0dfSc5d_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>治疗结直肠癌，全球首个非基因编辑的同种异体CAR-T临床项目公布1期临床结果丨医麦猛爆料</title>
    <updated>2021-01-19T11:50:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/zpIxyG0iiiFNegxA5Nxi_Q</id>
    <link href="https://mp.weixin.qq.com/s/zpIxyG0iiiFNegxA5Nxi_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首例！博雅辑因CRISPR/Cas9基因编辑疗法获批临床丨医麦猛爆料</title>
    <updated>2021-01-19T11:50:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/RcGfobkRWWyq-ejHO5HnlQ</id>
    <link href="https://mp.weixin.qq.com/s/RcGfobkRWWyq-ejHO5HnlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CD30 CAR-T进入后期临床开发阶段，聊一聊Tessa公司多种CAR疗法的开发方向丨医麦猛爆料</title>
    <updated>2021-01-19T11:50:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/3bE1WSXmAW5YIg2s74azeQ</id>
    <link href="https://mp.weixin.qq.com/s/3bE1WSXmAW5YIg2s74azeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛默飞9亿美元加码病毒载体制造，强化细胞与基因治疗产能丨医麦新观察</title>
    <updated>2021-01-19T11:50:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/QVk5A1YWNaNCxStIzW1d2A</id>
    <link href="https://mp.weixin.qq.com/s/QVk5A1YWNaNCxStIzW1d2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>